Is First Trust NYSE Arca Biotechnology Index Fund halal to invest in?

As of September 2026, First Trust NYSE Arca Biotechnology Index Fund FBT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is First Trust NYSE Arca Biotechnology Index Fund a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes First Trust NYSE Arca Biotechnology Index Fund using these criteria to determine its compliance status.

How often is the Shariah compliance for First Trust NYSE Arca Biotechnology Index Fund updated?

The Shariah compliance status of First Trust NYSE Arca Biotechnology Index Fund may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like First Trust NYSE Arca Biotechnology Index Fund become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of First Trust NYSE Arca Biotechnology Index Fund?

You can check the latest Shariah compliance status of First Trust NYSE Arca Biotechnology Index Fund on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

First Trust NYSE Arca Biotechnology Index Fund FBT

FBT Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, First Trust NYSE Arca Biotechnology Index Fund is classified as halal.

HALAL

Is First Trust NYSE Arca Biotechnology Index Fund ETF Halal?

Shariah Compliance Analysis of FBT ETF

US Equity Health Care

Yes. As of September 2026, First Trust NYSE Arca Biotechnology Index Fund (FBT) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. First Trust NYSE Arca Biotechnology Index Fund passes Musaffa's business and financial screening criteria.

FBT was created on 2006-06-19 by First Trust. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 1386.23m in AUM and 31 holdings. FBT tracks an equal-weighted index of US biotechnology stocks.

First Trust NYSE Arca Biotechnology Index Fund (FBT) Chart

Key Statistics of First Trust NYSE Arca Biotechnology Index Fund (FBT)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
88.67%
Other
11.33%

FAQ's for First Trust NYSE Arca Biotechnology Index Fund (FBT)

As of September 2026, First Trust NYSE Arca Biotechnology Index Fund FBT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes First Trust NYSE Arca Biotechnology Index Fund using these criteria to determine its compliance status.
The Shariah compliance status of First Trust NYSE Arca Biotechnology Index Fund may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of First Trust NYSE Arca Biotechnology Index Fund on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.